Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2025-08-20 Report Publication Anno…
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of newspaper advertisements about the upcoming 6th Annual General Meeting (AGM) and the record date for dividend payment. It references compliance with SEBI regulations and includes details about the AGM date and dividend record date. The document does not contain the AGM materials themselves, nor does it include financial statements or detailed reports. It is essentially an announcement about the publication of AGM-related information in newspapers and on the company's website. The document length is short (1744 characters), and it serves as a notification rather than the AGM presentation or report itself. Therefore, it fits best under Report Publication Announcement (RPA), as it announces the publication of AGM-related materials but does not contain the materials themselves.
2025-08-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q1 FY26 earnings conference call for Aarti Pharmalabs Limited, dated August 20, 2025. It includes management commentary on financial results, business segments, operational updates, and a Q&A session with analysts. The text explicitly mentions it is a transcript of the earnings call, referencing un-audited financial results for Q1 FY26. The content includes detailed financial figures, business outlook, and strategic updates typical of earnings call transcripts. There is no indication that this is a brief announcement or a report publication notice; rather, it is the full text of the call. Therefore, the document fits the definition of a Call Transcript (CT).
2025-08-20 English
Record Date
Notice of Dividend Amount Classification · 100% confidence The document is a letter addressed to stock exchanges regarding the record date for payment of the final dividend for the financial year 2024-25. It references the dividend amount, the record date, and the payment date, and mentions approval by shareholders at the upcoming Annual General Meeting. The document is short (1683 characters) and is an announcement about dividend payment details rather than the dividend report itself. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-08-19 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of unaudited financial results for the quarter ended June 30, 2025. It references compliance with SEBI Listing Regulations and states that the financial results have been published in newspapers. The document itself does not contain the financial results or detailed financial data but is an announcement about the publication of these results. The document length is short (1741 characters), and it primarily serves as a notification of the publication of the financial results rather than the report itself. According to the 'Menu vs Meal' rule, this fits the category of Report Publication Announcement (RPA).
2025-08-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges regarding the recording of an earnings conference call related to the company's un-audited financial results for the quarter ended June 30, 2025. It references Regulation 30 of SEBI (LODR) Regulations 2015 and provides a link to the audio recording of the call on the company's website. The document does not contain the transcript or detailed financial data itself, only an announcement about the availability of the recording. Given the short length (1301 characters) and the nature of the content (announcement of a conference call recording), this fits best as a Regulatory Filing (RNS) rather than a Call Transcript (CT) or Earnings Release (ER).
2025-08-13 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Results Presentation' and is addressed to stock exchanges referencing Regulation 30 of SEBI (LODR) Regulations 2015, which mandates disclosure of material events including earnings presentations. The content includes detailed company overview, business highlights, manufacturing capabilities, R&D, and quarterly revenue break-up for Q1-FY26. It is a presentation document intended for investors and the market, focusing on financials, strategy, and market position. The document is about 15,000 characters long and contains substantive content typical of an investor presentation rather than a brief announcement or a regulatory filing. Therefore, the document fits the category of an Investor Presentation (IP).
2025-08-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.